Publication | Open Access

The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model

MedicineCell DeathInhibits Tumor GrowthAnti-cancer AgentTumor SuppressorHuman Neuroblastoma CellsPharmacologyCell BiologyTumor BiologyCancer Growth